HelenJRossMD(She/Her)

Thoracic Cancer

Thoracic Medical Oncology Professor of Internal Medicine Chief, Division of Hematology, Oncology and Cellular Therapy Director of Research and Clinical Trials Rush University Cancer Center

Request Appointment

Overview of Dr. Ross

Dr. Helen Ross is an oncologist in Chicago, IL and is affiliated with Rush University Medical Center. She received her medical degree from David Geffen School of Medicine at UCLA and has been in practice 33 years. Dr. Ross accepts several types of health insurance, listed below. She is one of 58 doctors at Rush University Medical Center who specialize in Oncology. She has more than 100 publications and over 500 citings.

Office
Rush University Cancer Center
1520 W Harrison St
Chicago, IL 60607
Book by Phone+1(872) 276-9566

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
Cedars-Sinai Medical CenterResidency, Internal Medicine, 1984 - 1987
David Geffen School of Medicine at UCLAClass of 1984

Certifications & Licensure

IL State Medical License 2023 - 2026
AZ State Medical License 2007 - 2025
CA State Medical License 1985 - 2025
OR State Medical License 1997 - 2025
CO State Medical License 2022 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Trial of Poor Performance Status Patients (ToPPS) Start of enrollment: 2009 Jun 01
Completed
Phase 2
Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2012 Apr 01
Terminated
Phase 2, Phase 3
A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib Start of enrollment: 2012 Oct 01
Completed
Phase 1, Phase 2
Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer Start of enrollment: 2014 May 14
Completed
Phase 1, Phase 2
A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants Start of enrollment: 2013 Aug 01
Completed
Phase 2
Atezolizumab Immunotherapy in Patients With Advanced NSCLC Start of enrollment: 2017 Nov 01
Completed
Phase 2
Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer Start of enrollment: 2018 Aug 10
Terminated
Phase 1
CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer Start of enrollment: 2021 Mar 10
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

1107 citations
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, ope...
Luis Paz-Ares, M. Dvorkin, Y. Chen, Niels Reinmuth, Katsuyuki Hotta
Lancet. 2019-11-23
29 citations
Outcomes of Minimally Invasive Esophagectomy in Esophageal Cancer After Neoadjuvant Chemoradiotherapy
Susanne G. Warner, Yu Hui H. Chang, Harshita Paripati, Helen J. Ross, Jonathan B. Ashman
The Annals of Thoracic Surgery. 2014-02-01
135 citations
Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX ® vaccine in advanced-stage non-small-cell lung cancer
John Nemunaitis, Thierry Jahan, H Ross, Daniel H. Sterman, D Richards
Cancer Gene Therapy. 2006-06-01

Lectures

Phase II trial of atezolizumab before and after definitive chemoradiation for unresectable stage III NSCLC.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

Double Cancer Diagnosis Leads Arizona Couple to Mayo Clinic for CareDecember 3rd, 2017
Mesothelioma Patient Finds Complex, Comprehensive AnswerJuly 12th, 2017

Grant Support

Cyclosporine Enhancement Of Paclitaxel In Lung CancerNational Cancer Institute1997–1999
Cyclosporine Enhancement Of Paclitaxel In Lung CancerNational Cancer Institute1996–1997
Regulation Of Cytokine MRNA Stability In Tumor CellsNational Cancer Institute1991–1995

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Association for Cancer Research - AACR
Member
American Society for Radiation Oncology - ASTRO
Member
International Association for the Study of Lung Cancer
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Georgia Blue Choice HMO
BCBS Georgia Blue Open Access POS
BCBS Georgia BlueChoice Option POS
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment